Clinical Trial News and Research

RSS

$3.7 million to improve high blood pressure control

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has launched a $3.7 million, three-year educational effort to improve high blood pressure control nationwide.

5 Feb 2006

Study looks at placebo effect

The debate about the existence of a placebo effect has heated up over the past year as more and more lab experiments are detecting immediate physiological responses to placebos.

2 Feb 2006

Phase II clinical trial for new gene transfer drug study

As many as 8-10 million Americans have Peripheral Artery Disease (PAD), by age 70, roughly 20 percent of the population has it, and people with PAD face a six-to-seven times higher risk of heart attack or stroke.

2 Feb 2006

Vaccine against ricin safe and effective

Scientists at the University of Texas Southwestern Medical Center at Dallas, say a vaccine against the deadly toxin ricin is safe and effective.

31 Jan 2006

Women at greater risk of subsequent stroke than men

Among patients who have suffered a single stroke, researchers at the University of Pennsylvania School of Medicine, along with colleagues at other institutions, have found that severe stenosis, or narrowing, of the arteries in the head represents a major risk factor for the development of a subsequent stroke.

27 Jan 2006

Aston Academy investigates macular oedema

Aston Academy of Life Sciences, the clinical research hospital of Aston University, has recently been commissioned to assess the efficacy and safety of a specialist drug, Posurdex (Allergan Ltd, UK), which is used in the treatment of patients who suffer from a sight threatening condition, called macular oedema.

26 Jan 2006

Working your brain hard reduces risk of dementia

Research from the University of New South Wales (UNSW), Australia, provides the most convincing evidence to date that complex mental activity across people's lives significantly reduces the risk of dementia. The researchers found that such activity almost halves the incidence of dementia.

25 Jan 2006

Aspirin may not increase the risk of recurrent intracerebral hemorrhage

Aspirin is typically prescribed for people at risk of having an ischemic stroke to prevent blood clots. Because aspirin may cause bleeding, it is typically avoided in people who have had a hemorrhagic stroke, also called intracerebral hemorrhage.

25 Jan 2006

Bactrim could help HIV-infected children in poor countries

A new systematic review highlights strong results from a single study at the center of mounting support for worldwide use of the low-cost drug Bactrim to help HIV-infected children in poor countries.

25 Jan 2006

Aspirin therapy may be safe for some survivors of intracerebral hemorrhage

A study from the Stroke Service at Massachusetts General Hospital (MGH) has found that some patients who have survived an intracerebral hemorrhage - a stroke caused by bleeding in the brain - may be safely treated with aspirin to prevent future heart attacks or strokes caused by blood clots.

23 Jan 2006

Experts counter study's claim - men should continue prostate exams

A man has a one in six chance of being diagnosed with prostate cancer. Each year, more than 230,000 men are diagnosed with the disease. Doctors have traditionally recommended two tests for the early detection of prostate cancer; the prostate specific antigen (PSA) test and digital rectal exam (DRE) are used to detect abnormalities with the prostate gland.

23 Jan 2006

Bristol-Myers Squibb agrees to record securities litigation settlement with sweeping drug disclosure requirements announces Labaton Sucharow

After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.

23 Jan 2006

First-of-its-kind study in heart attack patients seeks to prevent heart failure with stem cells

University of Rochester Medical Center researchers have announced the launch of a study that will examine whether transplanted stem cells can be safely used to treat damaged heart muscle in patients just after their first heart attack.

23 Jan 2006

Vitamin D helps prevent bone loss during osteoporosis

The risk of bone fracture resulting from falls increases as we age due to bone loss and osteoporosis. Physicians have routinely prescribed vitamin D and vitamin D- related drugs to retard bone loss, but until now, little was known about the specific targets of vitamin D in bone.

22 Jan 2006

New study gives insight into the dairy and weight loss link

A new clinical trial published today in Obesity Research (the journal of NAASO, the Obesity Society) provides more insight into why consuming dairy foods is linked to weight and fat loss.

18 Jan 2006

Vioxx may still be the best option for treating some forms of arthritis

Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.

18 Jan 2006

Hopes dashed for peanut allergy drug Xolair

Hopes have been dashed for a potential treatment for peanut allergies following the severe reactions suffered by two children during a clinical trial.

18 Jan 2006

Abdominal chemotherapy boosts survival in ovarian cancer patients

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone

10 Jan 2006

FDA approves jaw joint prosthetic developed by University of Pennsylvania

After a 10-year clinical trial of a jaw joint replacement developed by Peter Quinn of the University of Pennsylvania School of Dental Medicine, the Food and Drug Administration has given it a thumbs-up.

10 Jan 2006

New combination treatment that could dramatically shorten the length of tuberculosis treatment

The clinical results of a new combination treatment that could dramatically shorten the length of tuberculosis treatment were presented at a recent scientific conference in the USA. This virulent disease of the lungs still infects millions every year, with a notable resurgence in Europe, especially in the East.

10 Jan 2006